Management of Acute Myocardial Infarction in the Presence of Left Bundle Branch Block
- Conditions
- Acute Coronary Syndrome
- Registration Number
- NCT01494870
- Lead Sponsor
- Samara Regional Cardiology Dispensary
- Brief Summary
The primary objective of this study is to propose new treatment algorithm (strategy) for patients with Acute Coronary Syndrome (ACS) and left bundle-branch block (LBBB).
- Detailed Description
Current recommendations on the treatment of acute coronary syndrome (ACS) dictate urgent reperfusion therapy in the case of evolving myocardial infarction with ST-segment elevation (STEMI). Optimal use of PCI (preferably) or thrombolysis in this situation requires a rapid and correct diagnosis.
According to the ESC'2008 and ACC/AHA'2009 focused update guidelines patients admitted to the hospital within 12 hours after the onset of chest pain with new (or presumably new) left bundle-branch block (LBBB) should be treated like patients having STEMI (class I, level A). However, it is well-known that in patients with concomitant LBBB, the ECG manifestations of acute myocardial injury may be masked.
ACS may occur in a patient with "true old" LBBB (when doctor has/has not an ability to compare the new ECG with the previous one) or (presumably) new LBBB.
There is a high risk of non receiving appropriate therapy or of receiving inappropriate therapy (thrombolysis instead of LMWH/UFH/fondaparinux).
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 300
- Age 18 - 75 years
- Ischemic discomfort (ie, ischemic chest pain or equivalent) at rest ≥20 minutes within previous 24 hours.
- Any (new, presumably new, or old) LBBB on the prehospital (ambulance) or admission ECG.
- Urgent coronary angiography (followed, when indicated, by PCI), ideally within 90 minutes after admission
- all-comers design
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method mortality 30 days
- Secondary Outcome Measures
Name Time Method Number of participants survived 1 year
Trial Locations
- Locations (1)
Samara Regional Cardiology Dispansery
🇷🇺Samara, Russian Federation
Samara Regional Cardiology Dispansery🇷🇺Samara, Russian FederationDmitry Duplyakov, MD, PhDPrincipal Investigator